Table 1.

Characteristics of the studies included in the systematic review and meta-analysis.

Reference	Year	N	Women (%)	Age	BMI	Design RCT	Participants’ Health Condition	Active Ingredients: Content and Dose	Duration	Outcome
Boix-Castejón et al. [15]	2018	47	100	51	29.7	Double blind, Parallel	Overweight/obesewomen	LC (35%), HC (65%); 500 mg; 1 capsule per day	8 weeks	Anthropometric parameters, vital signs, appetite assessment, health-related quality of life, and peptides and hormones
Boix-Castejón et al. [45]	2021	51	NR	NR	30	Double blind, Parallel	Stage 1 hypertensive patients	LC (65%), HC (35%); 250 mg; 2 capsules per day	6 weeks	Anthropometric parameters, blood analysis, blood pressure
Herranz-López et al. [46]	2019	46	100	51.5	30.1	Double blind, Parallel	Overweight/obesewomen	LC (65%), HC (35%); 250 mg; 2 capsules per day	8 weeks	Anthropometric parameters, vital signs, appetite assessment, biochemical parameters
Marhuenda et al. [47]	2021	76	22.5	34.8	29.6	Double blind, Parallel	Overweight/obese subjects	LC (65%), HC (35%); 500 mg; 1 capsule per day	12 weeks	Anthropometric parameters, blood analysis, blood pressure
Serna et al. [16]	2022	33	48.48	33.8	28.1	Double blind, Crossover	Overweight/obese subjects	LC (65%), HC (35%); 250 mg; 2 capsules per day	8 weeks	Anthropometric parameters, blood analysis, appetite assessment
Lee et al. [18]	2015	39	51.3	49.5	11.7	Double blind, Parallel	Adults with dyslipidemia	PFR, CF, PM, DL, VU, and HS at a ratio of 6:10:2:4:4:5, respectively	8 weeks	Anthropometric parameters, blood analysis, blood pressure
Khongrum et al. [17]	2022	40	72.5	36.5	4.9	Double blind, Parallel	Adults with dyslipidemia	300 mL jelly drink (44.53% w/w HS and 12.12% w/w PF)	8 weeks	Anthropometric parameters, blood analysis, blood pressure

BMI: body mass index, CF: Crataegi fructus, DL: Dolichos lablab, HS: Hibiscus sabdariffa, LC: Lippia citriodora, NR: not reported, PF: passion fruit, PFR: Perilla frutescens, PM: Prunus mume, RCT: randomized clinical trial, VU: Vigna umbellate.